{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T18:19:41Z","timestamp":1792433981683,"version":"4.5.0"},"reference-count":117,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.ad.2022.01.006","type":"journal-article","created":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T17:22:03Z","timestamp":1643822523000},"page":"481-490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Psoriasis ungueal"],"prefix":"10.1016","volume":"113","author":[{"given":"E.","family":"Canal-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Bosch-Amate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Belinch\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Puig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2022.01.006_bib0590","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10227-002-0143-0","article-title":"Psoriatic nails: a prospective clinical study","volume":"7","author":"Salomon","year":"2003","journal-title":"J Cutan Med Surg."},{"key":"10.1016\/j.ad.2022.01.006_bib0595","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ad.2011.02.007","article-title":"Nail psoriasis in individuals with psoriasis vulgaris: a study of 661 patients","volume":"102","author":"Armesto","year":"2011","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.ad.2022.01.006_bib0600","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jaad.2013.11.013","article-title":"Psoriasis prevalence among adults in the United States","volume":"70","author":"Rachakonda","year":"2014","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib0605","doi-asserted-by":"crossref","unstructured":"Rigopoulos D, Tosti A, editors. Nail Psoriasis: From A to Z. London: Springer; 2014.","DOI":"10.1007\/978-3-319-08810-5"},{"key":"10.1016\/j.ad.2022.01.006_bib0610","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3109\/1061186X.2014.929138","article-title":"Insights into drug delivery across the nail plate barrier","volume":"22","author":"Saner","year":"2014","journal-title":"J Drug Target."},{"key":"10.1016\/j.ad.2022.01.006_bib0615","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.hlc.2018.03.027","article-title":"An Introduction to Writing Narrative and Systematic Reviews \u2014 Tasks, Tips and Traps for Aspiring Authors","volume":"27","author":"Gregory","year":"2018","journal-title":"Heart Lung Circ."},{"key":"10.1016\/j.ad.2022.01.006_bib0620","first-page":"1","article-title":"Nail psoriasis: Epidemiological study in France","volume":"19","author":"Taieb","year":"2005","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.ad.2022.01.006_bib0625","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1525-1470.2007.00324.x","article-title":"Nail changes in childhood psoriasis: a study from Kuwait","volume":"24","author":"Al-Mutairi","year":"2007","journal-title":"Pediatr Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib0630","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1365-2133.2010.09831.x","article-title":"Nail psoriasis in Germany: epidemiology and burden of disease","volume":"163","author":"Augustin","year":"2010","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib0635","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/pde.12072","article-title":"Clinical manifestations of pediatric psoriasis: results of a multicenter study in the United States","volume":"30","author":"Mercy","year":"2013","journal-title":"Pediatr Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib0640","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jaad.2019.01.072","article-title":"Recommendations for the definition, evaluation, and treatment of nail psoriasis in adult patients with no or mild skin psoriasis: A dermatologist and nail expert group consensus","volume":"81","author":"Rigopoulos","year":"2019","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib0645","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2340\/00015555-3384","article-title":"Psoriasis and Genetics","volume":"100","author":"Dand","year":"2020","journal-title":"Acta Derm Venereol."},{"key":"10.1016\/j.ad.2022.01.006_bib0650","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jdermsci.2020.05.008","article-title":"The current landscape of psoriasis genetics in 2020","volume":"99","author":"Ogawa","year":"2020","journal-title":"J Dermatol Sci."},{"key":"10.1016\/j.ad.2022.01.006_bib0655","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1093\/hmg\/dds295","article-title":"Risk variants for psoriasis vulgaris in a large case-control collection and association with clinical subphenotypes","author":"Juli\u00e0","year":"2012","journal-title":"Hum Mol Genet."},{"key":"10.1016\/j.ad.2022.01.006_bib0660","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/ard.2010.144097","article-title":"The early phase of psoriatic arthritis","volume":"70","author":"McGonagle","year":"2011","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.ad.2022.01.006_bib0665","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/BOR.0b013e32832c6ab9","article-title":"The pathogenesis of psoriatic arthritis and associated nail disease: not autoimmune after all?","volume":"21","author":"McGonagle","year":"2009","journal-title":"Curr Opin Rheumatol."},{"key":"10.1016\/j.ad.2022.01.006_bib0670","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s10067-016-3319-5","article-title":"Psoriatic nail involvement and its relationship with distal interphalangeal joint disease","author":"Lai","year":"2016","journal-title":"Clin Rheumatol."},{"key":"10.1016\/j.ad.2022.01.006_bib0675","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/rheumatology\/kel214","article-title":"The relationship between the extensor tendon enthesis and the nail in distal interphalangeal joint disease in psoriatic arthritis--a high-resolution MRI and histological study","volume":"46","author":"Tan","year":"2007","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.ad.2022.01.006_bib0680","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ad.2015.02.005","article-title":"Nail psoriasis as a predictor of the development of psoriatic arthritis","volume":"106","author":"Raposo","year":"2015","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.ad.2022.01.006_bib0685","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/art.24172","article-title":"Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study","volume":"61","author":"Wilson","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ad.2022.01.006_bib0690","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/rheumatology\/keh198","article-title":"Extended report: nail disease in psoriatic arthritis--clinically important, potentially treatable and often overlooked","volume":"43","author":"Williamson","year":"2004","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.ad.2022.01.006_bib0695","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s10067-006-0476-y","article-title":"The relationship between nail- and distal phalangeal bone involvement severity in patients with psoriasis","volume":"26","author":"Serarslan","year":"2007","journal-title":"Clin Rheumatol."},{"key":"10.1016\/j.ad.2022.01.006_bib0700","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.3899\/jrheum.201471","article-title":"Nail Psoriasis: Diagnosis, Assessment Treatment Options, and Unmet Clinical Needs","volume":"48","author":"Kaeley","year":"2021","journal-title":"J Rheumatol."},{"key":"10.1016\/j.ad.2022.01.006_bib0705","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1439-0507.2011.02053.x","article-title":"Onychomycosis in patients with psoriasis--a multicentre study","volume":"55","author":"Zisova","year":"2012","journal-title":"Mycoses."},{"key":"10.1016\/j.ad.2022.01.006_bib0710","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/bjd.12354","article-title":"Nail psoriasis: a questionnaire-based survey","volume":"169","author":"Klaassen","year":"2013","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib0715","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/ijd.14364","article-title":"Factors associated with onychomycosis in nail psoriasis: a multicenter study in Pakistan","volume":"58","author":"Tabassum","year":"2019","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib0720","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.2147\/DDDT.S136986","article-title":"New insight into the pathogenesis of nail psoriasis and overview of treatment strategies","volume":"11","author":"Ventura","year":"2017","journal-title":"Drug Des Devel Ther."},{"key":"10.1016\/j.ad.2022.01.006_bib0725","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/cup.13334","article-title":"Clinical and histological spectrum of nail psoriasis: A cross-sectional study","volume":"45","author":"Kaul","year":"2018","journal-title":"J Cutan Pathol."},{"key":"10.1016\/j.ad.2022.01.006_bib0730","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2340\/00015555-3893","article-title":"A Deep Learning Approach for Histopathological Diagnosis of Onychomycosis: Not Inferior to Analogue Diagnosis by Histopathologists","volume":"101","author":"Decroos","year":"2021","journal-title":"Acta Derm Venereol."},{"key":"10.1016\/j.ad.2022.01.006_bib0735","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/ijd.13690","article-title":"Examining the importance of laboratory and diagnostic testing when treating and diagnosing onychomycosis","volume":"57","author":"Ghannoum","year":"2018","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib0740","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/jdv.14843","article-title":"Comparison of fungal fluorescent staining and ITS rDNA PCR-based sequencing with conventional methods for the diagnosis of onychomycosis","volume":"32","author":"Bao","year":"2018","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.ad.2022.01.006_bib0745","article-title":"Dermatophytic onychia: Effectiveness of rapid immunochromatographic diagnostic testing directly on samples compared to culture","author":"Paugam","year":"2021","journal-title":"Ann Dermatol Venereol."},{"key":"10.1016\/j.ad.2022.01.006_bib0750","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1365-2133.2011.10526.x","article-title":"Smoking and pathogenesis of psoriasis: a review of oxidative, inflammatory and genetic mechanisms","volume":"165","author":"Armstrong","year":"2011","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib0755","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/dth.13960","article-title":"The effect of smoking on the psoriasis: Is it related to nail involvement?","volume":"33","author":"Temiz","year":"2020","journal-title":"Dermatol Ther."},{"key":"10.1016\/j.ad.2022.01.006_bib0760","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2005.07.073","article-title":"Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy","volume":"57","author":"Jiaravuthisan","year":"2007","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib0765","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4103\/0019-5154.113955","article-title":"Finger nail pitting in psoriasis and its relation with different variables","volume":"58","author":"Singh","year":"2013","journal-title":"Indian J Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib0770","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1684\/ejd.2020.3841","article-title":"Clinical parameters associated with severity of nail psoriasis and therapeutic efficacy","volume":"30","author":"You","year":"2020","journal-title":"Eur J Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib0775","article-title":"A text atlas of nail disorders: techniques in investigation and diagnosis. 3rd ed","author":"Baran","year":"2003","journal-title":"CRC Press;"},{"key":"10.1016\/j.ad.2022.01.006_bib0780","first-page":"315","article-title":"Frequency of nail changes in patients with psoriasis reporting to PNS, Shifa Naval Hospital Karachi","volume":"22","author":"Idrees","year":"2012","journal-title":"J Pak Assoc Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib0785","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00000372-198306000-00012","article-title":"The \u00aboil drop\u00bb sign of psoriatic nails. A clinical finding specific for psoriasis","volume":"5","author":"Kouskoukis","year":"1983","journal-title":"Am J Dermatopathol."},{"key":"10.1016\/j.ad.2022.01.006_bib0790","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1111\/j.1468-3083.2011.04289.x","article-title":"Prevalence, severity and clinical features of psoriasis in fingernails and toenails in adult patients: Italian experience","volume":"26","author":"Brazzelli","year":"2012","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.ad.2022.01.006_bib0795","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1365-2133.2005.06862.x","article-title":"Diagnosis of nail psoriasis: importance of biopsy and histopathology","volume":"153","author":"Grover","year":"2005","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib0800","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1067\/S0190-9622(03)00910-1","article-title":"Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis","volume":"49","author":"Rich","year":"2003","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib0805","first-page":"123","article-title":"The modified Nail Psoriasis Severity Index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis","volume":"34","author":"Cassell","year":"2007","journal-title":"J Rheumatol."},{"key":"10.1016\/j.ad.2022.01.006_bib0810","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1111\/jdv.17387","article-title":"Development and validation of the Physician's Global Assessment of Fingernail Psoriasis","volume":"35","author":"Hudgens","year":"2021","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.ad.2022.01.006_bib0815","doi-asserted-by":"crossref","first-page":"28","DOI":"10.5114\/ada.2017.65618","article-title":"A study of dermoscopic features of nail psoriasis","volume":"34","author":"Yorulmaz","year":"2017","journal-title":"Postepy Dermatol Alergol."},{"key":"10.1016\/j.ad.2022.01.006_bib0820","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/1346-8138.15908","article-title":"Dermoscopic features of nail psoriasis: Positive correlation with the severity of psoriasis","volume":"48","author":"Long","year":"2021","journal-title":"J Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib0825","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000508165","article-title":"Dermoscopic Features of Nail Psoriasis: An Observational, Analytical Study","volume":"6","author":"Chauhan","year":"2020","journal-title":"Skin Appendage Disord."},{"key":"10.1016\/j.ad.2022.01.006_bib0830","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10067-014-2630-2","article-title":"Tailored approach to early psoriatic arthritis patients: clinical and ultrasonographic predictors for structural joint damage","volume":"34","author":"El Miedany","year":"2015","journal-title":"Clin Rheumatol."},{"key":"10.1016\/j.ad.2022.01.006_bib0835","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/RHU.0000000000000054","article-title":"Ultrasound nail imaging on patients with psoriasis and psoriatic arthritis compared with rheumatoid arthritis and control subjects","volume":"20","author":"Sandobal","year":"2014","journal-title":"J Clin Rheumatol."},{"key":"10.1016\/j.ad.2022.01.006_bib0840","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s10067-010-1623-z","article-title":"The role of ultrasound in rheumatic skin and nail lesions: a multi-specialist approach","volume":"30","author":"Wortsman","year":"2011","journal-title":"Clin Rheumatol."},{"key":"10.1016\/j.ad.2022.01.006_bib0845","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00403-012-1274-9","article-title":"Ultrasonography reveals nail thickening in patients with chronic plaque psoriasis","volume":"304","author":"Gisondi","year":"2012","journal-title":"Arch Dermatol Res."},{"key":"10.1016\/j.ad.2022.01.006_bib0850","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10067-009-1292-y","article-title":"A sonographic spectrum of psoriatic arthritis: \u00abthe five targets\u00bb","volume":"29","author":"Gutierrez","year":"2010","journal-title":"Clin Rheumatol."},{"key":"10.1016\/j.ad.2022.01.006_bib0855","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0001-7310(16)30008-4","article-title":"Ecograf\u00eda aplicada al manejo de la patolog\u00eda de la u\u00f1a","volume":"106","author":"Vidal","year":"2015","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.ad.2022.01.006_bib0860","doi-asserted-by":"crossref","first-page":"631","DOI":"10.4103\/0378-6323.57740","article-title":"Nail pitting and onycholysis","volume":"75","author":"Jadhav","year":"2009","journal-title":"Indian J Dermatol Venereol Leprol."},{"key":"10.1016\/j.ad.2022.01.006_bib0865","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1525-1470.1994.tb00562.x","article-title":"Prevalence of nail abnormalities in children with alopecia areata","volume":"11","author":"Tosti","year":"1994","journal-title":"Pediatr Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib0870","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2005.07.073","article-title":"Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy","volume":"57","author":"Jiaravuthisan","year":"2007","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib0875","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0733-8635(18)30880-5","article-title":"Trauma to the nail unit including occupational sports injuries","volume":"3","author":"Mortimer","year":"1985","journal-title":"Dermatol Clin."},{"key":"10.1016\/j.ad.2022.01.006_bib0880","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s40265-016-0564-5","article-title":"Nail Psoriasis: A Review of Treatment Options","volume":"76","author":"Pasch","year":"2016","journal-title":"Drugs."},{"key":"10.1016\/j.ad.2022.01.006_bib0885","first-page":"1","article-title":"Network meta-analysis comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis","author":"Reich","year":"2021","journal-title":"J Dermatolog Treat."},{"key":"10.1016\/j.ad.2022.01.006_bib0890","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1046\/j.1365-2133.1998.02462.x","article-title":"Calcipotriol ointment in nail psoriasis: a controlled double-blind comparison with betamethasone dipropionate and salicylic acid","volume":"139","author":"Tosti","year":"1998","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib0895","first-page":"912","article-title":"A randomized, double-blinded trial evaluating the efficacy and tolerability of vectical ointment (calcitriol 3 mcg\/g ointment) when compared to betamethasone diproprionate ointment (64mg\/g) in patients with nail psoriasis","volume":"13","author":"Kole","year":"2014","journal-title":"J Drugs Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib0900","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1468-3083.2005.01253.x","article-title":"Treatment of nail psoriasis with 8% clobetasol nail lacquer: positive experience in 10 patients","volume":"19","author":"S\u00e1nchez Rega\u00f1a","year":"2005","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.ad.2022.01.006_bib0905","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/archderm.1987.91660010035013","article-title":"Distal phalangeal atrophy secondary to topical steroid therapy","volume":"123","author":"Deffer","year":"1987","journal-title":"Arch Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib0910","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1080\/00015550252948220","article-title":"Nail psoriasis: a combined treatment using calcipotriol cream and clobetasol propionate cream","volume":"82","author":"Rigopoulos","year":"2002","journal-title":"Acta Derm Venereol."},{"key":"10.1016\/j.ad.2022.01.006_bib0915","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/j.1468-3083.2008.02679.x","article-title":"Nail psoriasis: a combined treatment with 8% clobetasol nail lacquer and tacalcitol ointment","volume":"22","author":"S\u00e1nchez Rega\u00f1a","year":"2008","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.ad.2022.01.006_bib0920","first-page":"279","article-title":"Calcipotriol used as monotherapy or combination therapy with betamethasone dipropionate in the treatment of nail psoriasis","volume":"88","author":"Tzung","year":"2008","journal-title":"Acta Derm Venereol."},{"key":"10.1016\/j.ad.2022.01.006_bib0925","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/j.1468-3083.2012.04642.x","article-title":"Tacrolimus 0.1% ointment in nail psoriasis: a randomized controlled open-label study","volume":"27","author":"De Simone","year":"2013","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.ad.2022.01.006_bib0930","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ad.2012.04.008","article-title":"Nail psoriasis: treatment with tazarotene 0.1% hydrophilic ointment","volume":"103","author":"Fischer-Levancini","year":"2012","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.ad.2022.01.006_bib0935","first-page":"355","article-title":"Tazarotene 0.1% gel in the treatment of fingernail psoriasis: a double-blind, randomized, vehicle-controlled study","volume":"68","author":"Scher","year":"2001","journal-title":"Cutis."},{"key":"10.1016\/j.ad.2022.01.006_bib0940","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1046\/j.1365-2133.2003.05392.x","article-title":"Tazarotene 0.1% gel for psoriasis of the fingernails and toenails: an open, prospective study","volume":"149","author":"Bianchi","year":"2003","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib0945","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1046\/j.1365-2133.1998.02031.x","article-title":"A simplified protocol of steroid injection for psoriatic nail dystrophy","volume":"138","author":"de Berker","year":"1998","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib0950","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2133.1973.tb02956.x","article-title":"Intradermal triamcinolone treatment of nail dystrophies","volume":"89","author":"Abell","year":"1973","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib0955","first-page":"78","article-title":"Treatment of nail psoriasis with a modified regimen of steroid injections","volume":"18","author":"Saleem","year":"2008","journal-title":"J Coll Physicians Surg Pak."},{"key":"10.1016\/j.ad.2022.01.006_bib0960","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4103\/idoj.IDOJ_280_18","article-title":"A Compendium of Intralesional Therapies in Nail Disorders","volume":"9","author":"Grover","year":"2018","journal-title":"Indian Dermatol Online J."},{"key":"10.1016\/j.ad.2022.01.006_bib0965","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1111\/jdv.13678","article-title":"Laser and light therapies for the treatment of nail psoriasis","volume":"30","author":"Maranda","year":"2016","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.ad.2022.01.006_bib0970","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1468-3083.2010.03938.x","article-title":"Nail psoriasis: a retrospective study on the effectiveness of systemic treatments (classical and biological therapy)","volume":"25","author":"S\u00e1nchez-Rega\u00f1a","year":"2011","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.ad.2022.01.006_bib0975","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2133.1987.tb05834.x","article-title":"Local PUVA treatment for nail psoriasis","volume":"116","author":"Handfield-Jones","year":"1987","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib0980","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/j.1468-3083.2009.03196.x","article-title":"Pulsed dye laser vs. photodynamic therapy in the treatment of refractory nail psoriasis: a comparative pilot study","volume":"23","author":"Fern\u00e1ndez-Guarino","year":"2009","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.ad.2022.01.006_bib0985","doi-asserted-by":"crossref","first-page":"134","DOI":"10.2340\/0001555572134136","article-title":"A double-blind study of superficial radiotherapy in psoriatic nail dystrophy","volume":"72","author":"Yu","year":"1992","journal-title":"Acta Derm Venereol."},{"key":"10.1016\/j.ad.2022.01.006_bib0990","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/ced.12960","article-title":"Six years\u2019 experience of grenz ray therapy for the treatment of inflammatory skin conditions","volume":"41","author":"Fenton","year":"2016","journal-title":"Clin Exp Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib0995","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1524-4725.2009.01448.x","article-title":"Pulsed dye laser in the treatment of nail psoriasis","volume":"36","author":"Oram","year":"2010","journal-title":"Dermatol Surg."},{"key":"10.1016\/j.ad.2022.01.006_bib1000","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/lsm.22122","article-title":"Efficacy of pulsed dye laser plus topical tazarotene versus topical tazarotene alone in psoriatic nail disease: a single-blind, intrapatient left-to-right controlled study","volume":"45","author":"Huang","year":"2013","journal-title":"Lasers Surg Med."},{"key":"10.1016\/j.ad.2022.01.006_bib1005","doi-asserted-by":"crossref","DOI":"10.3109\/14764172.2013.854627","article-title":"Clinical Trial Study in the Treatment of Nail Psoriasis with Pulsed Dye Laser","author":"Goldust","year":"2013","journal-title":"J Cosmet Laser Ther."},{"key":"10.1016\/j.ad.2022.01.006_bib1010","first-page":"1039","article-title":"Effectiveness of systemic treatment agents on psoriatic nails: a comparative study","volume":"12","author":"Demirsoy","year":"2013","journal-title":"J Drugs Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib1015","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1529-8019.2012.01539.x","article-title":"Treatment of severe nail psoriasis with acitretin: an impressive therapeutic result","volume":"26","author":"Ricceri","year":"2013","journal-title":"Dermatol Ther."},{"key":"10.1016\/j.ad.2022.01.006_bib1020","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1001\/archdermatol.2008.600","article-title":"Evaluation of the efficacy of acitretin therapy for nail psoriasis","volume":"145","author":"Tosti","year":"2009","journal-title":"Arch Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib1025","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/j.1468-3083.2010.03927.x","article-title":"Evaluation of the efficacy of methotrexate and cyclosporine therapies on psoriatic nails: a one-blind, randomized study","volume":"25","author":"G\u00fcm\u00fc\u015fel","year":"2011","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.ad.2022.01.006_bib1030","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1056\/NEJMoa1010858","article-title":"A 52-week trial comparing briakinumab with methotrexate in patients with psoriasis","volume":"365","author":"Reich","year":"2011","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ad.2022.01.006_bib1035","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0190-9622(95)90189-2","article-title":"Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement","volume":"32","author":"Mahrle","year":"1995","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib1040","first-page":"248","article-title":"Successful treatment of psoriatic nails with low-dose cyclosporine administration","volume":"17","author":"Syuto","year":"2007","journal-title":"Eur J Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib1045","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1177\/120347540400800208","article-title":"Nail psoriasis: combined therapy with systemic cyclosporin and topical calcipotriol","volume":"8","author":"Feliciani","year":"2004","journal-title":"J Cutan Med Surg."},{"key":"10.1016\/j.ad.2022.01.006_bib1050","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jaad.2015.03.049","article-title":"Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)","volume":"73","author":"Papp","year":"2015","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib1055","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/bjd.14164","article-title":"Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate-to-severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2)","volume":"173","author":"Paul","year":"2015","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib1060","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jaad.2015.09.001","article-title":"Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with difficult-to-treat nail and scalp psoriasis: Results of 2 phase III randomized, controlled trials (ESTEEM 1 and ESTEEM 2)","volume":"74","author":"Rich","year":"2016","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib1065","first-page":"1","article-title":"Apremilast as a target therapy for nail psoriasis: a real-life observational study proving its efficacy in restoring the nail unit","author":"Lanna","year":"2020","journal-title":"J Dermatolog Treat."},{"key":"10.1016\/j.ad.2022.01.006_bib1070","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1468-3083.2009.03453.x","article-title":"Treatment of nail psoriasis with adalimumab: an open label unblinded study","volume":"24","author":"Rigopoulos","year":"2010","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.ad.2022.01.006_bib1075","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jaad.2007.07.042","article-title":"Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year","volume":"58","author":"Rich","year":"2008","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib1080","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2133.2008.08686.x","article-title":"Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study","volume":"159","author":"Rigopoulos","year":"2008","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib1085","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000317775","article-title":"Skin and nail responses after 1 year of infliximab therapy in patients with moderate-to-severe psoriasis: a retrospective analysis of the EXPRESS Trial","volume":"221","author":"Reich","year":"2010","journal-title":"Dermatology."},{"key":"10.1016\/j.ad.2022.01.006_bib1090","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1346-8138.2011.01459.x","article-title":"Japanese Infliximab Study Investigators. Dramatic impact of a Psoriasis Area and Severity Index 90 response on the quality of life in patients with psoriasis: an analysis of Japanese clinical trials of infliximab","volume":"39","author":"Torii","year":"2012","journal-title":"J Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib1095","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/archdermatol.2010.384","article-title":"Adalimumab for treatment of moderate to severe chronic plaque psoriasis of the hands and feet: efficacy and safety results from REACH, a randomized, placebo-controlled, double-blind trial","volume":"147","author":"Leonardi","year":"2011","journal-title":"Arch Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib1100","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/jdv.12553","article-title":"Adalimumab for the treatment of moderate to severe psoriasis: subanalysis of effects on scalp and nails in the BELIEVE study","volume":"29","author":"Tha\u00e7i","year":"2015","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.ad.2022.01.006_bib1105","first-page":"1065","article-title":"A 36-week retrospective open trial comparing the efficacy of biological therapies in nail psoriasis","volume":"11","author":"Bardazzi","year":"2013","journal-title":"J Dtsch Dermatol Ges."},{"key":"10.1016\/j.ad.2022.01.006_bib1110","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1468-3083.2009.03211.x","article-title":"Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis","volume":"23","author":"Luger","year":"2009","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.ad.2022.01.006_bib1115","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/bjd.12060","article-title":"A 24-week randomized clinical trial investigating the efficacy and safety of two doses of etanercept in nail psoriasis","volume":"168","author":"Ortonne","year":"2013","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib1120","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000334482","article-title":"Efficacy of ustekinumab in nail psoriasis and improvement in nail-associated quality of life in a population treated with ustekinumab for cutaneous psoriasis: an open prospective unblinded study","volume":"223","author":"Rigopoulos","year":"2011","journal-title":"Dermatology."},{"key":"10.1016\/j.ad.2022.01.006_bib1125","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3109\/09546634.2011.607796","article-title":"Ustekinumab in nail psoriasis: an open-label, uncontrolled, nonrandomized study","volume":"24","author":"Patsatsi","year":"2013","journal-title":"J Dermatolog Treat."},{"key":"10.1016\/j.ad.2022.01.006_bib1130","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/bjd.12632","article-title":"Ustekinumab improves nail disease in patients with moderate-to-severe psoriasis: results from PHOENIX 1","volume":"170","author":"Rich","year":"2014","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib1135","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/bjd.19262","article-title":"Secukinumab shows high and sustained efficacy in nail psoriasis: 2.5-year results from the randomized placebo-controlled TRANSFIGURE study","volume":"184","author":"Reich","year":"2021","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib1140","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1111\/jdv.12996","article-title":"Improvement of scalp and nail lesions with ixekizumab in a phase 2 trial in patients with chronic plaque psoriasis","volume":"29","author":"Langley","year":"2015","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.ad.2022.01.006_bib1145","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/jdv.14033","article-title":"Ixekizumab treatment improves fingernail psoriasis in patients with moderate-to-severe psoriasis: results from the randomized, controlled and open-label phases of UNCOVER-3","volume":"31","author":"Van de Kerkhof","year":"2017","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.ad.2022.01.006_bib1150","first-page":"958","article-title":"Ixekizumab Is Effective in Subjects With Moderate to Severe Plaque Psoriasis With Significant Nail Involvement: Results From UNCOVER 3","volume":"15","author":"Dennehy","year":"2016","journal-title":"J Drugs Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib1155","first-page":"1","article-title":"Efficacy of brodalumab in the treatment of scalp and nail psoriasis: results from three phase 3 trials","author":"Elewski","year":"2020","journal-title":"J Dermatolog Treat."},{"key":"10.1016\/j.ad.2022.01.006_bib1160","doi-asserted-by":"crossref","first-page":"e299","DOI":"10.1111\/jdv.17055","article-title":"Treatment of nail psoriasis with brodalumab: an open-label unblinded study","volume":"35","author":"Gregoriou","year":"2021","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.ad.2022.01.006_bib1165","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1001\/jamadermatol.2018.0793","article-title":"Efficacy of Guselkumab Compared With Adalimumab and Placebo for Psoriasis in Specific Body Regions: A Secondary Analysis of 2 Randomized Clinical Trials","volume":"154","author":"Foley","year":"2018","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.ad.2022.01.006_bib1170","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0140-6736(18)31713-6","article-title":"Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials","volume":"392","author":"Gordon","year":"2018","journal-title":"Lancet."}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000173102200028X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000173102200028X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:12:55Z","timestamp":1757553175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000173102200028X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":117,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S000173102200028X"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2022.01.006","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psoriasis ungueal","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2022.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 AEDV. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}